| scholarly article | Q13442814 |
| P2093 | author name string | Jürgen K Willmann | |
| Lu Tian | |||
| Marybeth A Pysz | |||
| Ismayil Guracar | |||
| P2860 | cites work | Comparison of conventional time-intensity curves vs. maximum intensity over time for post-processing of dynamic contrast-enhanced ultrasound | Q39769691 |
| Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects | Q40024036 | ||
| Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature | Q40187867 | ||
| Expansion of endothelial surface by an increase of vessel diameter during tumor angiogenesis in experimental and hepatocellular and pancreatic cancer | Q40509107 | ||
| Assessment and monitoring tumor vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging | Q41966656 | ||
| Ultrastructural biologic effects of sonography with pulse inversion and microbubble contrast in rabbit liver. | Q42475350 | ||
| Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38). | Q44035899 | ||
| Differences in definity and optison microbubble destruction rates at a similar mechanical index with different real-time perfusion systems | Q44649294 | ||
| In vitro contrast-enhanced ultrasound measurements of capillary microcirculation: comparison between polymer- and phospholipid-shelled microbubbles. | Q45859695 | ||
| A method for differentiating targeted microbubbles in real time using subharmonic micro-ultrasound and interframe filtering. | Q52594810 | ||
| Inter-rater concordance study of the PASI (Psoriasis Area and Severity Index). | Q53077820 | ||
| A preliminary in vitro assessment of polymer-shelled microbubbles in contrast-enhanced ultrasound imaging. | Q53188123 | ||
| Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides. | Q22255481 | ||
| Acoustic radiation force enhances targeted delivery of ultrasound contrast microbubbles: in vitro verification | Q28247220 | ||
| An in vivo validation of the application of acoustic radiation force to enhance the diagnostic utility of molecular imaging using 3-d ultrasound | Q28260061 | ||
| Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha(v)-integrins | Q30310466 | ||
| Quantitative assessment of tumor angiogenesis using real-time motion-compensated contrast-enhanced ultrasound imaging | Q30408880 | ||
| scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis | Q30425448 | ||
| US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice | Q30431243 | ||
| Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. | Q30432690 | ||
| Dual frequency method for simultaneous translation and real-time imaging of ultrasound contrast agents within large blood vessels | Q30434058 | ||
| Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications | Q30439569 | ||
| Molecular body imaging: MR imaging, CT, and US. part I. principles | Q30454154 | ||
| Ultrasound for molecular imaging and therapy in cancer | Q30462662 | ||
| Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). | Q30474689 | ||
| Molecular ultrasound imaging: current status and future directions | Q30474725 | ||
| Molecular ultrasound assessment of tumor angiogenesis | Q30474770 | ||
| A sensitive TLRH targeted imaging technique for ultrasonic molecular imaging. | Q30477810 | ||
| Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo | Q30484195 | ||
| Molecular ultrasound imaging of early vascular response in prostate tumors irradiated with carbon ions. | Q30487248 | ||
| Acoustic response from adherent targeted contrast agents | Q30500915 | ||
| BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis | Q34089383 | ||
| Targeted contrast-enhanced ultrasound: an emerging technology in abdominal and pelvic imaging | Q34171483 | ||
| Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging | Q34591102 | ||
| Quantification and monitoring of inflammation in murine inflammatory bowel disease with targeted contrast-enhanced US. | Q35629916 | ||
| Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. | Q36890859 | ||
| Bioeffects considerations for diagnostic ultrasound contrast agents | Q37116582 | ||
| Molecular imaging using contrast-enhanced ultrasound: evaluation of angiogenesis and cell therapy | Q37560413 | ||
| Molecular sonography with targeted microbubbles: current investigations and potential applications | Q37760402 | ||
| Microbubble-enhanced US in body imaging: what role? | Q37790181 | ||
| Development of polymeric microbubbles targeted to prostate-specific membrane antigen as prototype of novel ultrasound contrast agents | Q39547572 | ||
| P433 | issue | 2 | |
| P921 | main subject | microbubble | Q6839290 |
| P304 | page(s) | 68-80 | |
| P577 | publication date | 2012-06-15 | |
| P1433 | published in | Quantitative imaging in medicine and surgery | Q26841874 |
| P1476 | title | Fast microbubble dwell-time based ultrasonic molecular imaging approach for quantification and monitoring of angiogenesis in cancer | |
| P478 | volume | 2 |
| Q30408549 | Binding dynamics of targeted microbubbles in response to modulated acoustic radiation force |
| Q27021416 | Cardiovascular molecular imaging with contrast ultrasound: principles and applications. |
| Q36498192 | Design considerations for targeted optical contrast agents |
| Q57575147 | Improved Sensitivity in Ultrasound Molecular Imaging With Coherence-Based Beamforming |
| Q30386016 | Intraoperative Contrast Enhanced Ultrasound Evaluates the Grade of Glioma. |
| Q38726749 | In vitro characterization and in vivo ultrasound molecular imaging of nucleolin-targeted microbubbles. |
| Q30279077 | Optical Verification of Microbubble Response to Acoustic Radiation Force in Large Vessels With In Vivo Results |
| Q64084113 | Real-time intraoperative ultrasound in brain surgery: neuronavigation and use of contrast-enhanced image fusion |
| Q33760851 | Structure-Inherent Targeting of Near-Infrared Fluorophores for Image-Guided Surgery |
| Q47234214 | Targeting of microbubbles: contrast agents for ultrasound molecular imaging. |
| Q30276184 | The Use of Acoustic Radiation Force Decorrelation-Weighted Pulse Inversion for Enhanced Ultrasound Contrast Imaging |
| Q30275871 | Ultra-Low-Dose Ultrasound Molecular Imaging for the Detection of Angiogenesis in a Mouse Murine Tumor Model: How Little Can We See? |
| Q49774225 | Ultrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human Results |
| Q30462662 | Ultrasound for molecular imaging and therapy in cancer |
| Q59133663 | Ultrasound molecular imaging as a non-invasive companion diagnostic for netrin-1 interference therapy in breast cancer |
| Q30375187 | Ultrasound molecular imaging: Moving toward clinical translation |
| Q30303105 | Ultrasound-based measurement of molecular marker concentration in large blood vessels: a feasibility study |
| Q38969661 | Use of VEGFR-2 targeted ultrasound contrast agent for the early evaluation of response to sorafenib in a mouse model of hepatocellular carcinoma. |
| Q37276919 | VEGFR2-Targeted Three-Dimensional Ultrasound Imaging Can Predict Responses to Antiangiogenic Therapy in Preclinical Models of Colon Cancer |
Search more.